O

Ochre Bio

52 employees

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma

Date founded

2019

Funding rounds raised

Total raised

$30M

from 16 investors over 16 rounds

O

Ochre Bio raised $30M on October 10, 2022

Investors: Lifeforce Capital, EIT Health, Khosla Ventures, Backed VC, Selvedge Venture and LIFELINK Ventures

O

Ochre Bio raised undisclosed on December 10, 2021

Investors: LIFELINK Ventures, Bioverge and Acequia Capital

O

Ochre Bio raised $9.6M on June 16, 2021

Investors: Hoxton Ventures, Apollo Ventures, Selvedge Venture, Khosla Ventures and Backed VC

O

Ochre Bio raised $150K on March 16, 2020

Investors: Expa and Y Combinator

FAQ